IP Library Granted Patent US 8,614,302
Granted Patent B2
US 8,614,302 · App. 12/129,641 · Granted Dec 24, 2013

Modified carbocyanine dyes and their conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,614,302
App. No.
12/129,641
Granted
Dec 24, 2013
Kind
B2
Abstract

Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.

Claims (31)

1. A compound of the formula:

and its salts, wherein

R 3 is L-S c , wherein L is a direct bond, or a group of 1-20 nonhydrogen atoms selected from the group consisting of C, N, O, P and S and is composed of any combination of ether, thioether, amine, ester, carboxamide, sulfonamide, hydrazide, aromatic and heteroaromatic bonds, and S c is an IgG antibody, concanavalin A, transferrin, streptavidin, R-phycoerythrin, allophycocyanin, aminophalloidin, an aminodextran, wheat germ agglutinin, amine-derivatized polystyrene microspheres, 5-(3-aminoallyl)-2′-deoxyuridine 5′-triphosphate, 5-(3-amino-1-propynyl)-2′-deoxyuridine 5′-triphosphate, 2′-(or 3′)-2-aminoethylaminocarbonyladenosine 5′-triphosphate, or tyramine;

R 4 is C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 methyl or ethyl;

R 2 is C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 sulfopropyl or sulfobutyl;

R 6 is H;

R 7 is sulfo;

R 8 is H;

R 9 is H;

R 16 is H;

R 17 is sulfo;

R 18 is H;

R 19 is H;

n is 1, 2 or 3;

R 12 is C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from the group consisting of N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, sulfopropyl or sulfobutyl;

R 13 is C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from the group consisting of N, O and S, and each alkyl portion of which is optionally substituted one or more times by substituents selected from the group consisting of F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 methyl;

R 14 is C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from the group consisting of N, O and S, and each alkyl portion of which is optionally substituted one or more times by substituents selected from the group consisting of F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 methyl, and

wherein sulfo is sulfonic acid or sulfonate.

2. The compound according to claim 1 , where S c is an IgG antibody, an aminodextran, or amine-derivatized polystyrene microspheres.

3. The compound according to claim 1 , where S c is concanavalin A, transferrin, streptavidin, R-phycoerythrin, allophycocyanin, wheat germ agglutinin, or aminophalloidin.

4. The compound according to claim 1 , where S c is 5-(3-aminoallyl)-2′-deoxyuridine 5′-triphosphate, 5-(3-amino-1-propynyl)-2′-deoxyuridine 5′-triphosphate, 2′-(or 3′)-2-aminoethylaminocarbonyladenosine 5′-triphosphate, or tyramine.

5. The compound according to claim 1 , where R 3 is —(CH 2 ) d (CONH(CH 2 ) e ) z′ —CO—S c

wherein:

S c is a conjugated substance selected from the group consisting of an IgG antibody, an aminodextran, and amine-derivatized polystyrene microspheres; and

d is 1-5; e is 1-5; and z′ is 0.

6. The compound according to claim 1 , where R 3 is —(CH 2 ) d (CONH(CH 2 ) e ) z′ —CO—S c wherein:

S c is a conjugated substance selected from the group consisting of concanavalin A, transferrin, streptavidin, R-phycoerythrin, allophycocyanin, wheat germ agglutinin, and aminophalloidin; and

d is 1-5; e is 1-5; and z′ is 0.

7. The compound according to claim 1 , where R 3 is —(CH 2 ) d (CONH(CH 2 ) e ) z′ —CO—S c wherein:

S c is a conjugated substance selected from the group consisting of 5-(3-aminoallyl)-2′-deoxyuridine 5′-triphosphate, 5-(3-amino-1-propynyl)-2′-deoxyuridine 5′-triphosphate, 2′-(or 3′)-2-aminoethylaminocarbonyladenosine 5′-triphosphate, and tyramine; and

d is 1-5; e is 1-5; and z′ is 0.

Assignments (2)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →